As of Feb 17
| 0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for Ocera Therapeutics Inc have a median target of 3.50, with a high estimate of 7.00 and a low estimate of 1.00. The median estimate represents a +442.64% increase from the last price of 0.65.
The current consensus among 4 polled investment analysts is to Buy stock in Ocera Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.